{"meta":{"query_hash":"11b50837ba6f","filters":{"venue":"Oncolytic Virotherapy"},"cohort_total":10,"direct_labels_cover":0,"predictions_cover":10,"exported":10,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/11b50837ba6f","api":"https://metacan.xera.ac/api/v1/cohort?venue=Oncolytic+Virotherapy"},"results":[{"id":"W1967880037","doi":"10.2147/ov.s31626","title":"Oncolytic virotherapy for ovarian cancer","year":2012,"lang":"en","type":"article","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; London Health Sciences Centre","funders":"National Cancer Institute; National Institute of Allergy and Infectious Diseases; Canadian Cancer Society Research Institute; National Institutes of Health","keywords":"Oncolytic virus; Ovarian cancer; Virotherapy; Cancer; Carcinogenesis; Clinical trial; Medicine; Oncology; Biology; Cancer research; Computational biology; Bioinformatics; Internal medicine","score_opus":0.03151637678982602,"score_gpt":0.3604665557516404,"score_spread":0.32895017896181433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967880037","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6879545,0.24627551,0.03839988,0.0023541225,0.00057159667,0.00038367795,0.00047772584,0.0005181023,0.023064919],"genre_scores_gemma":[0.92632055,0.057496473,0.009790974,0.00030414845,0.00008712803,0.00011460324,0.00030587046,0.0000412077,0.0055390606],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99994314,0.000013448357,0.0000033917274,0.000008340692,0.000020146948,0.000011590114],"domain_scores_gemma":[0.999977,0.000005372975,0.000005935092,0.0000028425543,0.0000027757933,0.0000060861958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017458478,0.00015573401,0.00020860188,0.00038715082,0.00015695451,0.00033381078,0.000117866475,0.00024452194,0.00085467944],"category_scores_gemma":[0.0001486762,0.00008406198,0.00021136356,0.00023523044,0.0002194159,0.00020158148,0.0003087855,0.00042947714,0.00018565028],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005483098,0.00021066856,0.0012540744,0.00066050136,0.000062040905,0.000319231,0.00016870482,0.00221293,0.79897213,0.008338073,0.0023699752,0.18488336],"study_design_scores_gemma":[0.00053911784,0.0030624582,0.00763392,0.0002033302,0.00016212612,0.0031974437,0.00011338008,0.00815282,0.7000658,0.004998849,0.27182615,0.00004463838],"about_ca_topic_score_codex":0.0005758538,"about_ca_topic_score_gemma":0.0011314098,"teacher_disagreement_score":0.00085467944,"about_ca_system_score_codex":0.00048757586,"about_ca_system_score_gemma":0.00042986753,"threshold_uncertainty_score":0.0035376549},"labels":[],"label_agreement":null},{"id":"W1977362391","doi":"10.2147/ov.s59640","title":"The emerging therapeutic potential of the oncolytic immunotherapeutic Pexa-Vec (JX-594)","year":2015,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Vaccinia; Immunotherapy; Hepatocellular carcinoma; Cancer research; Cancer; Medicine; Immunology; Colorectal cancer; Immune system; Virotherapy; Biology; Internal medicine","score_opus":0.03707615220644535,"score_gpt":0.3786682573576426,"score_spread":0.34159210515119726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977362391","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003909877,0.9970554,0.0003131979,0.00024679565,0.00016717847,0.0000060779876,0.000030654974,0.000010695315,0.0017790924],"genre_scores_gemma":[0.002024964,0.996005,0.0003740891,0.00025906463,0.00011039561,0.000009913457,0.000059990434,0.0000026338234,0.0011540632],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999056,0.000012673828,0.00001125076,0.000019484987,0.000038090133,0.0000128868],"domain_scores_gemma":[0.9998859,0.00005112735,0.000016432501,0.0000033365714,0.00002983899,0.000013333118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003020571,0.00048085264,0.00062131527,0.0016120187,0.00017706462,0.00072140084,0.00037272155,0.0007649296,0.0027098183],"category_scores_gemma":[0.00030578562,0.00020479824,0.0003879945,0.0010524677,0.00026979716,0.00091815117,0.00045520134,0.0014856375,0.0012181475],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006489007,0.00007004596,0.00016238111,0.012675838,0.00006141477,0.00022475628,0.00006354298,0.00042356114,0.008864796,0.004658231,0.018905504,0.9538252],"study_design_scores_gemma":[0.000011372252,0.00010681679,0.00051447336,0.0011156059,0.00006818771,0.0012856842,0.00003057295,0.00008454829,0.0019574647,0.0011303885,0.99368143,0.000013481733],"about_ca_topic_score_codex":0.0005717875,"about_ca_topic_score_gemma":0.00094427355,"teacher_disagreement_score":0.0027098183,"about_ca_system_score_codex":0.0004389374,"about_ca_system_score_gemma":0.00061992137,"threshold_uncertainty_score":0.009065211},"labels":[],"label_agreement":null},{"id":"W1992223911","doi":"10.2147/ov.s45525","title":"The ex vivo purge of cancer cells using oncolytic viruses: recent advances and clinical implications","year":2015,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ontario Institute for Cancer Research; Ottawa Hospital","funders":"","keywords":"Oncolytic virus; Vesicular stomatitis virus; Ex vivo; Virus; Herpes simplex virus; Immunology; Context (archaeology); Vaccinia; Cancer; Virology; Cancer research; Medicine; Biology; In vivo; Internal medicine","score_opus":0.1445093680993037,"score_gpt":0.501463198130461,"score_spread":0.3569538300311573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992223911","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023070037,0.998161,0.0003372673,0.00011934145,0.00010500616,0.0000046786804,0.000013477818,0.0000085190595,0.0010200235],"genre_scores_gemma":[0.0010252938,0.9977164,0.00041239208,0.00009392209,0.0000535939,0.000007124011,0.00003024872,0.0000026042162,0.0006583392],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998568,0.00002135978,0.00001802859,0.00003143462,0.00005623491,0.000016061575],"domain_scores_gemma":[0.9997434,0.00012686047,0.000034526583,0.000010312123,0.00006195919,0.000022836026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055549026,0.00074595393,0.0009055419,0.0017612324,0.00021472575,0.00094881834,0.00063019176,0.00086212583,0.0020502713],"category_scores_gemma":[0.00050025334,0.0003079629,0.00045403646,0.0016450218,0.00047277985,0.0012603578,0.0006119827,0.0014232927,0.0014199209],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006439726,0.00007949945,0.00017702248,0.012037494,0.00006417875,0.0001562881,0.00005787747,0.00053736416,0.007259631,0.004392955,0.01112382,0.96404946],"study_design_scores_gemma":[0.00001106261,0.00012512034,0.00050613313,0.0011584111,0.00007640944,0.0009739624,0.00004298363,0.0001236802,0.0032241582,0.0014526821,0.99228525,0.000020186138],"about_ca_topic_score_codex":0.0005724936,"about_ca_topic_score_gemma":0.0009984691,"teacher_disagreement_score":0.0020502713,"about_ca_system_score_codex":0.0005427889,"about_ca_system_score_gemma":0.00071128085,"threshold_uncertainty_score":0.0068588853},"labels":[],"label_agreement":null},{"id":"W1998536901","doi":"10.2147/ov.s36623","title":"Cell carriers for oncolytic viruses: current challenges and future directions","year":2013,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Virus; Limiting; Virology; Immune system; Virotherapy; Medicine; Biology; Cancer research; Immunology","score_opus":0.07115610492401497,"score_gpt":0.38587240996775035,"score_spread":0.3147163050437354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998536901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011548331,0.998317,0.00026492562,0.00039442795,0.00018347817,0.000005205749,0.000009779956,0.000008666361,0.00070104876],"genre_scores_gemma":[0.0005439267,0.9980902,0.0003514034,0.00019942629,0.00012668694,0.000010223715,0.000018808327,0.0000022579559,0.0006570078],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99970716,0.00005291933,0.000029221708,0.000041996034,0.0001334122,0.000035379384],"domain_scores_gemma":[0.9995328,0.00022751045,0.000049671173,0.000014740126,0.00013031403,0.000044865697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013449263,0.0009300998,0.0015275257,0.0018364324,0.0003655658,0.0016267761,0.0011174126,0.0018217439,0.004839435],"category_scores_gemma":[0.0008423285,0.00043648522,0.00055247394,0.0016665935,0.00081282074,0.0032333343,0.00089406,0.0024900185,0.00350559],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007080342,0.00010690905,0.00012280197,0.012294044,0.000041371368,0.00029069374,0.00010049116,0.00054987735,0.004777333,0.010623572,0.027873056,0.94314903],"study_design_scores_gemma":[0.00001564224,0.00008775184,0.00021209847,0.0017238971,0.000035153847,0.000763851,0.00007348622,0.00013823352,0.0010357148,0.0030405747,0.992855,0.000018601873],"about_ca_topic_score_codex":0.0011333583,"about_ca_topic_score_gemma":0.0018155695,"teacher_disagreement_score":0.004839435,"about_ca_system_score_codex":0.000894467,"about_ca_system_score_gemma":0.0012768813,"threshold_uncertainty_score":0.016189575},"labels":[],"label_agreement":null},{"id":"W2063924821","doi":"10.2147/ov.s51321","title":"Reovirus in cancer therapy: an evidence-based review","year":2014,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":68,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University","funders":"","keywords":"Cancer; Cancer therapy; Medicine; Internal medicine","score_opus":0.30804080071913004,"score_gpt":0.528756644501325,"score_spread":0.22071584378219494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063924821","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000043802465,0.99933237,0.000039529044,0.00017570936,0.00010626864,0.000009702385,0.000022052252,0.000003124222,0.00026745352],"genre_scores_gemma":[0.0003391465,0.99917275,0.000095207055,0.00017378479,0.00008505363,0.00001063534,0.000030953455,8.53275e-7,0.0000916248],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.999514,0.00012050908,0.00013396762,0.00006139038,0.00013244589,0.000037746104],"domain_scores_gemma":[0.9986279,0.0008222545,0.00021503217,0.00002104374,0.00026145726,0.000052450425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012079995,0.0009741218,0.0022923204,0.003316118,0.00031547,0.001590657,0.0013200282,0.0014820456,0.0051326817],"category_scores_gemma":[0.0023293023,0.00030499254,0.0015451779,0.0031046413,0.00033710914,0.0014796131,0.0006884608,0.0016013301,0.001198428],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015966104,0.000077513134,0.00019550962,0.1603577,0.00046191676,0.00016673363,0.00007374211,0.00038301566,0.0007305463,0.0017427295,0.028900433,0.80675054],"study_design_scores_gemma":[0.00009145997,0.00028459053,0.001291233,0.09774575,0.0023750823,0.0012802464,0.00011229851,0.00016117624,0.00035808538,0.0016882984,0.89457273,0.000039098653],"about_ca_topic_score_codex":0.0014889863,"about_ca_topic_score_gemma":0.0026547292,"teacher_disagreement_score":0.0051326817,"about_ca_system_score_codex":0.0008465032,"about_ca_system_score_gemma":0.0028212187,"threshold_uncertainty_score":0.017170489},"labels":[],"label_agreement":null},{"id":"W2168122442","doi":"10.2147/ov.s66079","title":"Mechanistic insights into the oncolytic activity of vesicular stomatitis virus in cancer immunotherapy","year":2015,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre","funders":"","keywords":"Oncolytic virus; Vesicular stomatitis virus; Virotherapy; Immunotherapy; Virus; Immunogenicity; Virology; Vesicular Stomatitis; Cancer immunotherapy; Medicine; Immunology; Immune system","score_opus":0.0450872497709337,"score_gpt":0.3856185311832006,"score_spread":0.3405312814122669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168122442","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00034716766,0.996403,0.0004918567,0.00031087486,0.00017202902,0.0000065301924,0.000017511287,0.000008818026,0.0022423405],"genre_scores_gemma":[0.0019265322,0.9968323,0.00031699328,0.00012739589,0.00005993597,0.0000078483,0.000018767056,0.000001220912,0.0007090744],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9999094,0.000015947835,0.000011047606,0.000016726965,0.00003084315,0.000015950403],"domain_scores_gemma":[0.99990845,0.0000402462,0.000010830373,0.0000045250817,0.000024046754,0.000011819155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044689752,0.0005772851,0.0007839716,0.0014703969,0.00029791016,0.0010254224,0.00056754635,0.0009903385,0.001922543],"category_scores_gemma":[0.00031535813,0.0002981662,0.0003975317,0.0012844384,0.0005278647,0.001540457,0.0006792176,0.0017440211,0.0013181467],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113673166,0.00017248627,0.00023747396,0.02178016,0.00009257158,0.0005806494,0.00022816705,0.0017117908,0.024233256,0.051476736,0.019953756,0.87941927],"study_design_scores_gemma":[0.000011132744,0.00009107367,0.000358044,0.001394603,0.000043951066,0.00093338755,0.00005758841,0.0001769381,0.0028152163,0.005845878,0.9882543,0.000017847446],"about_ca_topic_score_codex":0.00054862304,"about_ca_topic_score_gemma":0.000885445,"teacher_disagreement_score":0.001922543,"about_ca_system_score_codex":0.00080139673,"about_ca_system_score_gemma":0.00097353535,"threshold_uncertainty_score":0.0064315796},"labels":[],"label_agreement":null},{"id":"W2227073990","doi":"10.2147/ov.s66083","title":"Cancer immunotherapy via combining oncolytic virotherapy with chemotherapy: recent advances","year":2016,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research","funders":"Rosetrees Trust; National Institute for Health and Care Research","keywords":"Oncolytic virus; Virotherapy; Immunotherapy; Immunogenic cell death; Medicine; Cancer; Cytotoxic T cell; Cancer research; Immune system; Clinical trial; Chemotherapy; Immunology; Biology; Internal medicine; In vitro","score_opus":0.026545109675986202,"score_gpt":0.36646457713543984,"score_spread":0.3399194674594536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2227073990","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018858342,0.9986512,0.00016688777,0.00012653567,0.000094417475,0.0000044930275,0.00000796549,0.000005886495,0.00075401907],"genre_scores_gemma":[0.00089279347,0.99833834,0.00019060643,0.00009704985,0.000077135584,0.000006173434,0.000015841246,0.0000013411654,0.00038068913],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998592,0.000023592296,0.000017944,0.000029072204,0.000053514665,0.000016629914],"domain_scores_gemma":[0.9998615,0.00006766988,0.00001864615,0.000005440002,0.000031868796,0.000014954792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004908667,0.0006699226,0.0009907405,0.0015801723,0.0001957695,0.0008508466,0.000635191,0.00080302695,0.0021198916],"category_scores_gemma":[0.0003747299,0.00025567468,0.00045388457,0.0014946153,0.00045747048,0.0011177065,0.0006187577,0.0015345702,0.0010462302],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008512468,0.000107332395,0.0001433748,0.01473919,0.00008174939,0.00017383098,0.00006799137,0.0005413639,0.0051426673,0.0043254443,0.012980313,0.96161157],"study_design_scores_gemma":[0.000022048866,0.00015269736,0.0005140058,0.001418351,0.00009040526,0.0011936788,0.000040111652,0.00013229925,0.0016751663,0.0017254277,0.9930194,0.000016409156],"about_ca_topic_score_codex":0.0005552071,"about_ca_topic_score_gemma":0.0010736489,"teacher_disagreement_score":0.0021198916,"about_ca_system_score_codex":0.0005500516,"about_ca_system_score_gemma":0.00067322294,"threshold_uncertainty_score":0.0070917606},"labels":[],"label_agreement":null},{"id":"W2320627933","doi":"10.2147/ov.s66217","title":"High-throughput screening to enhance oncolytic virus immunotherapy","year":2016,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"Government of Canada; Terry Fox Research Institute; Ontario Institute for Cancer Research","keywords":"Oncolytic virus; Vaccinia; Herpes simplex virus; Virus; Computational biology; Disease; Biology; CRISPR; Virology; Medicine; Gene; Genetics","score_opus":0.03293868116363912,"score_gpt":0.3924652041768385,"score_spread":0.3595265230131994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320627933","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029988452,0.9714481,0.011553004,0.00048651165,0.0004402866,0.00014937506,0.00019120782,0.00022690254,0.012505757],"genre_scores_gemma":[0.015929218,0.9684475,0.006972744,0.00050233497,0.00015468882,0.00012537146,0.00029638188,0.000033138334,0.0075386586],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99953806,0.000073310075,0.000029541801,0.00006493877,0.00024622784,0.000048000627],"domain_scores_gemma":[0.9997887,0.00008694724,0.000029733943,0.000013063566,0.00006408613,0.000017550406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074881007,0.0010438613,0.0012873552,0.0025110934,0.00026162722,0.0011523898,0.0008752346,0.0011747394,0.0032508918],"category_scores_gemma":[0.0005448929,0.000494209,0.00085857575,0.0016196581,0.0004365332,0.0013355451,0.0007444222,0.0017263211,0.002769198],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013056716,0.00038875444,0.00041831326,0.017784707,0.00022525199,0.00053510483,0.00013793929,0.0023581723,0.11271172,0.013786551,0.0290114,0.82251155],"study_design_scores_gemma":[0.00004148397,0.0003207659,0.0010457708,0.0009243706,0.0001566307,0.0016824867,0.000056741672,0.0012312025,0.06614257,0.0024788212,0.92585385,0.00006536603],"about_ca_topic_score_codex":0.00054464577,"about_ca_topic_score_gemma":0.001116422,"teacher_disagreement_score":0.0032508918,"about_ca_system_score_codex":0.00087377476,"about_ca_system_score_gemma":0.0006101153,"threshold_uncertainty_score":0.010875344},"labels":[],"label_agreement":null},{"id":"W2794593274","doi":"10.2147/ov.s137159","title":"The importance of imaging strategies for pre-clinical and clinical in vivo distribution of oncolytic viruses","year":2018,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Oncolytic virus; Virotherapy; Medicine; In vivo; Clinical trial; Cancer; Medical physics; Biology; Biotechnology; Pathology; Internal medicine","score_opus":0.08023557482088156,"score_gpt":0.4780869901824264,"score_spread":0.39785141536154484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2794593274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00030139866,0.99581736,0.000800791,0.00044496768,0.00020826685,0.000010232695,0.000020794661,0.000016355356,0.0023798924],"genre_scores_gemma":[0.002152223,0.99521166,0.0010434443,0.00028867048,0.00016104593,0.00001794983,0.00003742957,0.000005115169,0.0010825741],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997218,0.000057445108,0.00003093675,0.000044239096,0.000120292534,0.000025193123],"domain_scores_gemma":[0.99950397,0.0002636797,0.000054406843,0.000016849488,0.00013400603,0.00002698901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007610085,0.00061350054,0.0009021939,0.0020073222,0.0002582407,0.0011186961,0.0006532015,0.0014265337,0.0025310596],"category_scores_gemma":[0.0008428335,0.0002849542,0.0005266372,0.0011531997,0.0005679075,0.0016474458,0.00055163435,0.0021499568,0.001474911],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063228625,0.00010030919,0.0002792128,0.015691483,0.00005657765,0.00036622045,0.00014039555,0.0006266148,0.015675167,0.009824149,0.020412227,0.93676436],"study_design_scores_gemma":[0.000008327566,0.000112459464,0.00054269657,0.0017557036,0.00005963172,0.0018254312,0.00007306015,0.00017050878,0.0049168104,0.0021229037,0.98838997,0.00002250734],"about_ca_topic_score_codex":0.0007658847,"about_ca_topic_score_gemma":0.0010545859,"teacher_disagreement_score":0.0025310596,"about_ca_system_score_codex":0.0006942621,"about_ca_system_score_gemma":0.0009465637,"threshold_uncertainty_score":0.008467197},"labels":[],"label_agreement":null},{"id":"W2901585058","doi":"10.2147/ov.s154494","title":"Development and applications of oncolytic Maraba virus vaccines","year":2018,"lang":"en","type":"review","venue":"Oncolytic Virotherapy","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; Ottawa Hospital; Wilfrid Laurier University; University of Ottawa; McMaster University Medical Centre; St. Joseph’s Healthcare Hamilton; University of Guelph; McMaster University","funders":"","keywords":"Oncolytic virus; Virus; Priming (agriculture); Immune system; Cancer; Vaccination; Virology; Antigen; Cancer vaccine; Viral vector; Medicine; Acquired immune system; Immunotherapy; Immunology; Biology; Cancer research; Internal medicine","score_opus":0.04029798762587887,"score_gpt":0.3695247003395902,"score_spread":0.3292267127137113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2901585058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00042371647,0.9978096,0.00032752624,0.00022883253,0.00014724603,0.000007659898,0.00001598044,0.000008603004,0.0010309628],"genre_scores_gemma":[0.0022298538,0.9965912,0.00031985427,0.00013617458,0.00008182566,0.00001066849,0.000030388452,0.0000017143682,0.00059829565],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998778,0.000021294834,0.000016612168,0.000023252851,0.00004417192,0.000016866179],"domain_scores_gemma":[0.9999082,0.00003545358,0.000015028136,0.0000039140814,0.00002674993,0.000010709348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040188656,0.00056534813,0.000696355,0.001916793,0.0001938851,0.0006146852,0.00046905724,0.0006986171,0.0016388935],"category_scores_gemma":[0.0003525821,0.00028442708,0.00041037917,0.000892111,0.0002825395,0.00080721895,0.0004520247,0.0014456945,0.0008201333],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008891371,0.000107806925,0.00020772047,0.017716976,0.00008112448,0.00033272713,0.000108815264,0.00087723305,0.01366968,0.0090768775,0.014730838,0.9430012],"study_design_scores_gemma":[0.000014659901,0.0001291011,0.0005063325,0.0016972974,0.000056480458,0.0012851302,0.00003832561,0.00016165288,0.0032361224,0.0019324819,0.9909276,0.000015017759],"about_ca_topic_score_codex":0.00050589687,"about_ca_topic_score_gemma":0.00085153064,"teacher_disagreement_score":0.001916793,"about_ca_system_score_codex":0.00050333585,"about_ca_system_score_gemma":0.0006668812,"threshold_uncertainty_score":0.005482614},"labels":[],"label_agreement":null}]}